Ata uhi

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB

Substantiation. The Juvenile Idiopathic Arthritis (JIA) is the most frequent rheumatic disease at children and is characterized by primary damage of joints, and also pathology of other bodies and fabrics with formation of polyorgan insufficiency of various degree of expressiveness. Research objectiv...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	V. A. Kel'tsev (Author), L. I. Grebenkina (Author), E. D. Moiseeva (Author)
Hōputu:	Pukapuka
I whakaputaina:	Union of pediatricians of Russia, 2015-04-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
mā: V. A. Kel'tsev, me ētahi atu.
I whakaputaina: (2012)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
mā: V. А. Kel'tsev, me ētahi atu.
I whakaputaina: (2014)

EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
mā: V. A. Kel'tsev, me ētahi atu.
I whakaputaina: (2012)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
mā: V. A. Keltsev, me ētahi atu.
I whakaputaina: (2016)

EFFECTIVENESS OF CYCLOSPORINE IN SYSTEMIC TYPE OF JUVENILE IDIOPATHIC ARTHRITIS
mā: V.A. Kel'tsev, me ētahi atu.
I whakaputaina: (2010)

EFFECTIVENESS OF CYCLOSPORINE IN SYSTEMIC TYPE OF JUVENILE IDIOPATHIC ARTHRITIS
mā: V.A. Kel'tsev, me ētahi atu.
I whakaputaina: (2010)

EXPERIENCE OF APPLICATION IBUPROFEN IN CHILDREN AND THE ADOLESCENT SICK JUVENILE IDIOPATHIC OF THE ARTHRITIS
mā: V.A. Kel'tsev, me ētahi atu.
I whakaputaina: (2007)

EXPERIENCE OF APPLICATION IBUPROFEN IN CHILDREN AND THE ADOLESCENT SICK JUVENILE IDIOPATHIC OF THE ARTHRITIS
mā: V.A. Kel'tsev, me ētahi atu.
I whakaputaina: (2007)

EXPERIENCE OF TREATMENT OF THE TWINS SICK WITH JUVENILE IDIOPATHIC ARTHRITIS BY ABATACEPT
mā: V. A. Kel'tsev
I whakaputaina: (2014)

Dynamics of Destructive Joint Changes in Juvenile Idiopathic Arthritis in Children who Received Methotrexate or Methotrexate-Tocilizumab Combination: a Cohort Study
mā: Maria A. Davydova, me ētahi atu.
I whakaputaina: (2018)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
mā: Anders Öman, me ētahi atu.
I whakaputaina: (2021)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
mā: E. V. Udachkina, me ētahi atu.
I whakaputaina: (2015)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
mā: E. V. Udachkina, me ētahi atu.
I whakaputaina: (2015)

Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
mā: Ekaterina Alexeeva, me ētahi atu.
I whakaputaina: (2019)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
mā: Serena ePastore, me ētahi atu.
I whakaputaina: (2015)

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
mā: Sonja Falvey, me ētahi atu.
I whakaputaina: (2017)

EXPERIENCE OF THE EFFICIENT USING OF METHOTREXATE FOR SUBCUTANEOUS ADMINISTRATION IN PATIENT WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
mā: S. A. Ushakova, me ētahi atu.
I whakaputaina: (2014)

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
mā: Benucci M, me ētahi atu.
I whakaputaina: (2017)

POSSIBLE PARENTERAL METHOTREXATE APPLICATION IN THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
mā: Yu. М. Spivakovsky, me ētahi atu.
I whakaputaina: (2014)

Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
mā: Novik GA, me ētahi atu.
I whakaputaina: (2011)

Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
mā: van Wijk Femke, me ētahi atu.
I whakaputaina: (2011)

Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors
mā: Estefanía Barral Mena, me ētahi atu.
I whakaputaina: (2020)

RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF HYPODERMIC METHOTREXATE INJECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
mā: E. I. Alexeeva, me ētahi atu.
I whakaputaina: (2013)

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
mā: Julia E. Möhlmann, me ētahi atu.
I whakaputaina: (2024)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
mā: Bambang Setyohadi, me ētahi atu.
I whakaputaina: (2018)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
mā: E. I. Alekseeva, me ētahi atu.
I whakaputaina: (2016)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
mā: T. V. Sleptsova, me ētahi atu.
I whakaputaina: (2013)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
mā: Tzaribachev N, me ētahi atu.
I whakaputaina: (2008)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
mā: Pluijm Saskia M F, me ētahi atu.
I whakaputaina: (2011)

EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
mā: T. V. Sleptsova, me ētahi atu.
I whakaputaina: (2013)

Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
mā: Nini Kyvsgaard, me ētahi atu.
I whakaputaina: (2021)

TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
mā: E.I. Alexeeva, me ētahi atu.
I whakaputaina: (2011)

TOCILIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
mā: E.I. Alexeeva, me ētahi atu.
I whakaputaina: (2011)

Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
mā: T. M. Bzarova, me ētahi atu.
I whakaputaina: (2016)

EXPERIENCE OF INTRAMUSCULAR METHOTREXATE USE IN A PATIENT WITH EARLY POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
mā: E. I. Alexeeva, me ētahi atu.
I whakaputaina: (2014)

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
mā: Rosanne M. Smits, me ētahi atu.
I whakaputaina: (2020)

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
mā: Giovanna Ferrara, me ētahi atu.
I whakaputaina: (2018)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
mā: Hofer M, me ētahi atu.
I whakaputaina: (2011)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
mā: Sleptsova T, me ētahi atu.
I whakaputaina: (2011)

The Efficiency of Adalimumab in Cases of Chronic Methotrexate-Resistant Juvenile Idiopathic Arthritis-Associated Anterior Uveitis: Retrospective Case Series Study
mā: E. V. Gaidar, me ētahi atu.
I whakaputaina: (2016)